You have 9 free searches left this month | for more free features.

FLT-PET

Showing 1 - 25 of 4,660

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)

Recruiting
  • Brain Tumor
  • Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Oct 6, 2022

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

FLT-PET / MRI Brain Mets

Recruiting
  • Brain Metastases
  • Radionecrosis
    • Toronto, Ontario, Canada
      University Health Network
    Oct 6, 2022

    Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)

    Active, not recruiting
    • Breast Neoplasm
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Hospital
    Aug 16, 2022

    Image, Body, Cervix Cancer Trial in Singapore ([18F]FLT-PET/MRI body scan)

    Recruiting
    • Image, Body
    • Cervix Cancer
    • [18F]FLT-PET/MRI body scan
    • Singapore, Singapore
      National Cancer Centre Singapore
    Apr 27, 2022

    Small Cell Lung Cancer Trial in Copenhagen (FLT-PET, MRI)

    Completed
    • Small Cell Lung Cancer
    • FLT-PET
    • MRI
    • Copenhagen, Denmark
      Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshosp
    May 3, 2022

    Advanced Cancer Trial in Houston (FLT-PET)

    Completed
    • Advanced Cancer
    • FLT-PET
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 3, 2022

    Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))

    Active, not recruiting
    • Graft Vs Host Disease
    • Fluorothymidine (FLT)
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Mar 21, 2022

    Response to Immune Checkpoint Blockade in Metastatic Melanoma

    Completed
    • Melanoma
    • F-FDG PET/CT
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Jul 7, 2022

    Non Small Cell Lung Cancer (NSCLC) Trial in Toronto (FLT-PET)

    Active, not recruiting
    • Non Small Cell Lung Cancer (NSCLC)
    • FLT-PET
    • Toronto, Ontario, Canada
      University Health Network
    Oct 1, 2021

    Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)

    Completed
    • Neurofibromatosis
    • MPNST
    • MRI, FDG-PET/CT scans
    • [18F]-FLT-PET/CT scans
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    NSCLC, Starting Pemetrexed Based Therapy, Unresectable Cancer Trial in Philadelphia (Baseline 18F-thymidine (FLT) PET/CT,

    Terminated
    • Non-small Cell Lung Cancer
    • +2 more
    • Baseline 18F-thymidine (FLT) PET/CT
    • +2 more
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    May 11, 2021

    Brain Tumors Trial in Boston ([18F] FLT)

    Active, not recruiting
    • Brain Neoplasms
    • [18F] FLT
    • Boston, Massachusetts
      Children's Hospital, Boston
    Aug 15, 2021

    FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large

    Completed
    • Lymphoma
    • +2 more
    • FLT-PET/CT
    • +2 more
    • Los Angeles, California
    • +3 more
    May 6, 2021

    [18F] Flourothymidine PET/CT Imaging for Gynecologic Cancers

    Completed
    • Gynecologic Cancer
    • [18F]Fluorothymidine (FLT) PET/CT Imaging
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 5, 2021

    Cancer, Brain Tumors Trial in Salt Lake City (FLT-PET Imaging)

    Completed
    • Cancer
    • Brain Tumors
    • FLT-PET Imaging
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Sep 20, 2021

    Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)

    Completed
    • Cancer
    • Non Small Cell Lung Cancer
    • PET Imaging
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 16, 2021

    Breast Cancer Trial (18F-FLT-PET/CT Imaging)

    Completed
    • Breast Cancer
    • 18F-FLT-PET/CT Imaging
    • (no location specified)
    Jan 20, 2021

    Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)

    Recruiting
    • Recurrent Non-Small Cell Lung Carcinoma
    • +3 more
    • Detroit, Michigan
      Wayne State University/Karmanos Cancer Institute
    Mar 30, 2022

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

    Recruiting
    • Brain and Central Nervous System Tumors
    • +8 more
    • 3'-deoxy-3'-[18F]fluorothymidine
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 30, 2022

    Tumors of the CNS Trial in Boston (18F-FLT, PET Imaging)

    Terminated
    • Tumors of the Central Nervous System
    • Boston, Massachusetts
      Children's Hospital Boston
    Oct 12, 2021

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Unknown status
    • Essential Thrombocythemia
    • +2 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Sep 27, 2020

    FLT-PET/MRI for Early Response Monitoring to Novel Cancer

    Completed
    • Unspecified Adult Solid Tumor, Protocol Specific
    • fluorine F 18 fluorothymidine
    • +2 more
    • Cleveland, Ohio
      Case Comprehensive Cancer Center
    Sep 17, 2020

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Terminated
    • Essential Thrombocythemia
    • +3 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Aug 10, 2020